A one-fifth dose of Bavarian Nordic’s mpox vaccine Jynneos can elicit a similar antibody response as its standard-dose regimen, according to findings presented Saturday at the European Society of ...
Ritchie Torres filed legislation this week aimed at improving the HHS' response to mpox and other health emergencies.
By the time the U.S. placed its orders, the vaccine’s Denmark-based manufacturer, Bavarian Nordic, was unable to satisfy demand for months, the New York Times uncovered. The U.S. didn’t ...
Emergent BioSolutions Inc. beats earnings expectations. Reported EPS is $0.59, expectations were $-0.86. Emergent ...
EBS earnings call for the period ending March 31, 2024. Emergent BioSolutions ( EBS 2.66%) Q1 2024 Earnings Call May 01, 2024 ...
Bavarian Nordic launches mpox vaccine in United States Semaglutide ... for approval by Jiuyuan Gene Engineering comes amid ...
Bavarian Nordic A/S - ADR does not currently pay a dividend. The outlook for the Pharmaceuticals sub-industry is positive as the world returns to normalcy and demand for electives ... to arise getting ...